Tharimmune

Biotech

Micro-Cap Biotech Firm Soars 200% on Fentanyl, Ultrapotent Opioids Breakthrough

Tharimmune (NASDAQ: THAR) stunned Wall Street on Wednesday, with its stock surging more than 200% after announcing positive simulation results…

Read More »
Back to top button